Improving the odds for infants with heart disease.

Our minimally invasive technology is changing lives.
Hypoplastic Left Heart Syndrome (HLHS) is a birth defect affecting normal blood flow through the heart.

Newborns with this condition require open heart surgery within the first days of life. Unfortunately, these infants are fragile. Without intervention, they will die. Even with state-of-the-art surgery, their risk of dying during the first operation is between 5 and 20% and their chance of surviving without a transplant to 5 years is about 60%.

Delaying open heart surgery for even a few months dramatically increases the baby’s chance of survival.

Kids deserve more

Technology designed with intention.

The Atlas and Ohm Stent System will provide a minimally invasive, temporary solution designed specifically for newborns with HLHS to improve and stabilize blood flow to the body until the infant is mature enough to handle open heart reconstruction.

Picture of a baby after surgery
  • Designed for newborns.
  • Minimally invasive, delaying open heart surgery on infants.
  • Cost-effective, reversible solution performed in the cardiac catheterization lab.
  • Reduces in-hospital recovery.

The Atlas Stent

A nitinol stent with symmetric radial strength to maintain patency of the ductus arteriosus. The Atlas stent can be delivered and removed using minimally invasive techniques.


The Ohm Resistor

Prevents pulmonary over-circulation using an EPTFE Funnel to provide ideal blood flow. The Ohm resistor is designed for minimally invasive delivery and removal while preserving artery geometry.

Disclaimer: Not available for sale. No guarantee of commercial viability.

Contact us to learn more.